News & Articles
Selected Filters:
Cost-Effective Exome Analysis in Hereditary Diseases
Precision Monitoring of More Than 15 Common Cancers now Feasible with GATCLIQUID ONCOTARGET
Highly specific assays allow for detection of minor allele frequencies down to 0.1%
Breaking New Ground in Transcriptomics: Resolve Full-Length Transcripts for Unprecedented Insights into Novel Isoforms and Disease-Causing Splicing Variants
GATC Biotech’s INVIEW TRANSCRIPTOME ISOFORM DISCOVER establishes a new quality standard for all isoform-related research
GATCLIQUID ONCOTARGET Expanded to Cover Blood Cancers such as Acute Myeloid Leukemia
Liquid biopsy test from GATC Biotech offers non-invasive analysis of 12 actionable genomic alterations in circulating cell-free DNA
GATC Biotech Expands Oncology Product Line with INVIEW ONCOPANEL for Solid Tumor Profiling
Direct comparative studies now possible with a set of cancer-specific genes for DNA from tumor tissue or for circulating tumor DNA from liquid biopsy samples
GATC Biotech’s Liquid Biopsy Testing Starts from as Little as EUR 195 Per Sample
GATC Biotech takes also the lead in terms of costs of liquid biopsy testing supporting early implementation of such assays by providing easy technology accessibility to researchers in clinical and translational medicine
GATC Biotech Offers the First Global Liquid Biopsy Service for Clinical Research and Translational Medicine
GATC Biotech Offers the First Global Liquid Biopsy Service for Clinical Research and Translational Medicine
GATC Biotech: Ultra-Deep and Ultra-Long Amplicon Sequencing to Boost Targeted Sequencing
GATC Biotech releases two new products for analysis of PCR fragments of up to 3 kb with highly sensitive detection and accuracy of up to 99.5%.